Hasil Pencarian - Shilpi Dhawan

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Evaluation of efficacy, safety, and tolerability of fixed dose combination (FDC) of halometasone 0.05% and fusidic acid 2% w/w topical cream versus FDC of betamethasone valerate 0.12% and neomycin sulphate 0.5% w/w topical cream in the treatment of infected eczematous dermatosis in Indian subjects: A randomized open-label comparative phase III multi-centric trial

    Evaluation of efficacy, safety, and tolerability of fixed dose combination (FDC) of halometasone 0.05% and fusidic acid 2% w/w topical cream versus FDC of betamethasone valerate 0.... oleh Dasiga Venkata Subrahmanya Pratap, Mariam Philip, Narayana T Rao, Hemangi R Jerajani, Sainath A Kumar, Maria Kuruvila, Latha S Moodahadu, Shilpi Dhawan

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study

    Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study oleh H R Jerajani, A S Kumar, Maria Kuruvila, H V Nataraja, Mariam Philip, D V S Pratap, T K Sumathy, Binny Krishnankutty, Shilpi Dhawan, Dennis Thomas

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-19

    Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-1... oleh Sajad Khaliq Dar, Sudershan Kumar, Sovan Maiti, Shilpi Dhawan, Sadhna Joglekar, Upasana Arora, Rinku Kalra, Sumit Madan, Altaf A. Lal, Venugopal Singamaneni, Prasoon Gupta, Utpal Nandi, Deepika Singh, Arshad H. Khuroo

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study

    Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study oleh Asim K. Ghosh, Usha S. Nikumbh, Chaitanya K. Shukla, Rohit S. Laul, Abhishek Dixit, Santosh K. Mahapatra, Sameera Nayak, Urmil M. Shah, Sandeep Parwal, Narendran Venkatapathy, Natasha Radhakrishnan, Anup Kelgaonkar, Sandeep Saxena, Divyansh Mishra, Vivek Pravin Dave, Perwez Khan, Manojkumar R. Saswade, Malli S. Shantilal, Kim Ramasamy, Smitha Sreekanta, Mandodari Rajurkar, Maulik Doshi, Sapan Behera, Piyush Patel, Shilpi Dhawan, Lalit Lakhwani

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: